Sema4 - About the company
Sema4 is a public company based in Stamford (United States), founded in 2017 by Eric Schadt. It operates as a Provider of genome-based diagnostic testing solutions for reproductive health and oncology. Sema4 has raised $241M in funding from investors like Blackstone, BlackRock and Connecticut Innovations. The company has 122 active competitors, including 24 funded and 18 that have exited. Its top competitors include companies like Natera, LifeCell and Lantern Pharma.
Company Details
Provider of genome-based diagnostics solutions for reproductive health and oncology. The company's platform helps physicians and patients to engage health data from genome test results, clinical records, wearable sensor metrics, and other sources. The company also offers a health intelligence platform.
- Website
- sema4.com
- Social
- Phone Number
- +1 **********
- Registered Address
- 333 Ludlow Street, North Tower, 8th floor Stamford, CT 06902
Key Metrics
Founded Year
2017
Location
Stamford, United States
Stage
Public
Total Funding
$241M in 3 rounds
Latest Funding Round
Investors
Ranked
10th among 122 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2025
Employee Count
141 as on Jun 30, 2026
Exit Details
Public
Legal entities associated with Sema4
Sema4 is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SEMA4 OPCO, INC. CIN: 85-1966622 , United States, Active | Oct 15, 2015 | - | 1200 (As on Dec 31, 2021) | - |
GENEDX HOLDINGS CORP. CIN: 1818331 , United States, Active | Jul 09, 2020 | $100M - $500M (As on Dec 31, 2025) | 1200 (As on Dec 31, 2021) | - |
Sema4's IPO details
Sema4 got listed on Sep 04, 2020.
Click here to take a look at Sema4's IPO in detail
Sign up to download Sema4's company profile
Sema4's funding and investors
Sema4 has raised a total funding of $241M over 3 rounds. Its first funding round was on Aug 2019. Its latest funding round was a Post IPO round on May 02, 2022 for $*****. 1 investor participated in its latest round. Sema4 has 8 institutional investors.
Here is the list of recent funding rounds of Sema4:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 02, 2022 | 3329716 | Post IPO | 9336210 | 6331995 | 8429278 | 9099675 |
Jul 29, 2020 | 9021532 | Series C | 1334638 | 4448773 | 3751403 | |
Aug 2019 | 4484054 | Series B | 3636644 | 5817297 | 7721341 |
Access funding benchmarks and valuations. Sign up today!View details of Sema4's funding rounds and investors
Sema4's founders and board of directors
Founder? Claim ProfileThe founders of Sema4 is Eric Schadt.
Here are the details of Sema4's key team members:
- Eric Schadt: Founder & CEO of Sema4.
View details of Sema4's Founder profiles and Board Members
Sema4's employee count trend
Sema4 has 141 employees as of Jun 26. Here is Sema4's employee count trend over the years:
Uncover Sema4's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sema4's Competitors and alternates
Top competitors of Sema4 include Natera, LifeCell and Lantern Pharma. Here is the list of Top 10 competitors of Sema4, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 77/100 | |
2nd | A stem cell banking company specializing in cord blood and tissue preservation | $61.2M | 74/100 | ||
3rd |  Lantern Pharma 2013, Dallas (United States), Public | Developing drug and companion diagnostics for multi-drug resistant cancers | $7.12M | 62/100 | |
4th | GeneDx 2000, Gaithersburg (United States), Acquired | Provider of genetic testing for inherited disorders | - | 62/100 | |
5th |  Nucleus Genomics 2021, Manhattan (United States), Series A | Provider of genetic testing kits for rare variant analysis | $32M | 62/100 | |
6th | Provider of an AI based cancer therapy management software for researchers and doctors | $61.7M | 59/100 | ||
7th |  ArcherDX 2013, Boulder (United States), Acquired | Developer of molecular cancer diagnostic products | $153M | 58/100 | |
8th | Developer of diagnostic kits for pathogen detection and viral load monitoring | - | 57/100 | ||
9th |  RareCyte 2009, Seattle (United States), Series C | Developer of technologies for the analysis of rare and single cells in the blood | $114M | 57/100 | |
10th | Sema4 2017, Stamford (United States), Public | Provider of genome-based diagnostic testing solutions for reproductive health and oncology | $241M | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Sema4's competitors? Click here to see the top ones
Sema4's Investments and acquisitions
Sema4 has acquired 3 companies including GeneDx, LifeMap Solutions and GeneDx. Sema4 has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 18, 2022 | Acquisition | 2000 | Gaithersburg (United States) | |
Aug 08, 2017 | Acquisition | 2014 | San Jose (United States) | |
Aug 29, 2006 | Acquisition | 2000 | Gaithersburg (United States) |
Want to know more about where corporates are investing? Sign up today!Reports related to Sema4
Here is the latest report on Sema4's geography:
News related to Sema4
Filter this list•
NTx Expands Commercial and Operational Teams to Accelerate GrowthTullahoma News•Apr 27, 2023•NTxBio, Sema4
•
•
Sema4 Reports Third Quarter 2022 Financial Results and New Strategic DirectionGlobeNewswire•Nov 14, 2022•Sema4
•
•
•
•
•
•
•
Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Sema4 Holdings CorpPR Newswire•Nov 03, 2022•Kclass Law, Sema4
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Sema4
Explore our recently published companies
- Wolters Kluwer - Alphen Aan Den Rijn based, 1836 founded, Unfunded company
- Lescento - Hudson based, Unfunded company
- Jaylonsoilsandmore - 2021 founded, Unfunded company
- Kinetix Engineering - Bengaluru based, 2006 founded, Seed company
- Opulentiastore - New Rochelle based, Unfunded company
- HashMedia - Nairobi based, 2018 founded, Unfunded company
